Herpesvirus saimiri transformation of HIV type 1 suppressive CD8+ lymphocytes from an HIV type 1-infected asymptomatic individual

AIDS Research and Human Retroviruses

Volumn 14, Issue 6, 1998, Pages 521-531

  Lacey, Simon F ^a   Weinhold, Kent J ^a   Chen, Chin Ho ^a   McDanal, Charlene ^a   Oei, Coreen ^a   Greenberg, Michael L ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ARTICLE; CELL TRANSFORMATION; HERPES VIRUS SAIMIRI; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0032502655     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.521     Document Type: Article

References (57)

1. Piatak M Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk K-C, Hahn BH, Shaw GM, and Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-1754.
2. Patterson BK, Till M, Otto P, Goolsby C, Furtado MR, McBride LJ, and Wolinsky SM: Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 1993;260:976-979.
3. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 1993;362:355-358.
4. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, and Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:359-362.
5. Ho DD, Moudgil T, and Alam M: Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-1625.
6. Coombs RW, Collier AC, Allain J-P, Mikora B, Leuther M, Gjerset GF, and Corey L: Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989;321:1626-1631.
7. Eyster ME, Ballard JO, Gail MH, Drummond JE, and Goedert JJ: Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: Persistence of p24 antigen and low T4 cell count. Ann Intern Med 1989;110:963-969.
8. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, and Ho DD: Temporal association of cellular immune responses with the initial control of viraemia in primary human immunodeficiency viras type I syndrome. J Virol 1994;68:4650-4655.
9. + cytotoxic T-lymphocyte activity associated with control of viraemia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-6110.
10. Greenberg ML, Lacey SF, Chen C-H, Bolognesi DP, and Weinhold KJ: Noncytolytic CD8 T cell-mediated suppression of HIV replication. Springer Semin Immunopathol 1997;18:355-369.
11. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563-1566.
12. + cells. Evidence for a soluble inhibitor. J Immunol 1990;144:2961-2966.
13. + cells involves an noncytotoxic mechanism. J Virol 1991;65: 5921-5927.
14. + T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell Immunol 1991;137:420-428.
15. + cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 1991;87:1462-1466.
16. + counts and clinical stage of disease. Clin Exp Immunol 1994;97:68-75.
17. Cao Y, Qin L, Zhang L, Safrit J, and Ho DD: Virological and immunological characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332: 201-208.
18. + T-lymphocyte-mediated inhibition of HIV-1 LTR transcription: A novel antiviral mechanism. AIDS Res Hum Retroviruses 1993;9:1079-1086.
19. + T cells is not lentivirus specific. AIDS Res Hum Retroviruses 1995;11:1321-1326.
20. + T cells suppress human immunodeficiency virus replication by inhibiting transcription. Proc Natl Acad Sci USA 1995;92:2308-2312.
21. + T cells derived from non-human primates. Clin Exp Immunol 1993;91:473-481.
22. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, and Lusso P: Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8 T cells. Science 1995;279:1811-1815.
23. Feng Y, Broder CD, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
24. Oberlin E, Amara A, Bacheleria F, Bessia C, Virelizier J-L, Arenzana-Seisdedos F, Schwarz O, Heard J-M, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, and Moser B: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (London) 1996;382: 833-835.
25. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, and Springer TA: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV entry. Nature (London) 1996;382:829-832.
26. + T cell suppression of syncytia-inducing strains of HIV-1. Proc Natl Acad Sci USA 1997;94:9842-9847.
27. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, and Honjo T: Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF-1) gene. Genomics 1995;28:495-500.
28. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA: CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
29. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, Larosa G, Newman W, Gerard N, Gerard C, and Sodroski J: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
30. Deng HK, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis C, Peiper SC, Schall TJ, Littman DR, and Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature (London) 1996;381:661-666.
31. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper S, Parmentier M, Collman RG, and Doms RW: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell 1996;85:1149-1158.
32. Dragic T, Litwin V, Allaway GP, Martin S, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, and Paxton WA: HIV-1 entry into CD4 cells is mediated by the chemokine receptor CC-CKR-5 Nature (London) 1996;381:667-673.
33. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, Mac-Donald ME, Stuhlman H, Koup RA, and Landau NR: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV infection. Cell 1996;86: 367-377.
34. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, and Parmentier M: Resistance to HIV infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (London) 1996;382:722-725.
35. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, and O'Brien SJ: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-1862.
36. Alkhatib G, Liao F, Berger EA, Farber JM, and Peden KWC: A new SIV co-receptor, STRL33. Nature (London) 1997;388:238.
37. Deng H, Unutmaz D, KewalRamani VN, and Littman DR: Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature (London) 1997;388:296-300.
38. Liao F, Alkhatib G, Peden KWC, Sharma G, Berger EA, and Farber JM: STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T-cell line-tropic HIV-1. J. Exp Med 1997;185:2015-2033.
39. Pleskoff O, Treboute C, Brelot, Heveker N, Seman M, and Alizon M: Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV entry. Science 1997;276: 1874-1878.
40. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder SB, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, and O'Brien SJ: contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997; 277:959-965.
41. Baier M, Wermer A, Bannert A, Metzner K, and Kurth R: HIV suppression by interleukin-16. Nature (London) 1995;378:563.
42. Maciaszek JW, Parada NA, Cruikshank WW, Center DM, Kornfeld H, and Viglianti GA: IL-16 represses HIV-1 promoter activity. J Immunol 1997;158:5-8.
43. Zhou P, Goldstein S, Devadas K, Tewari D, and Notkins AL: Human CD4 cells transfected with IL16 cDNA are resistant to HIV-1 infection: Inhibition of mRNA expression. Nature Med 1997; 3:659-664.
44. + T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous chemokines. Proc Natl Acad Sci USA 1996;93:14076-14081.
45. + cells. Immunol Today 1996;17:217-224.
46. + T-cell-derived soluble factor(s) but not β-chemokines RANTES, MIP-1α and MIP-1β, suppress HIV-1 replication in monocyte/macrophages. Proc Natl Acad Sci USA 1996;93: 15341-15345.
47. + T cell-mediated suppression of HIV replication: β chemokine-dependent and -independent effects. AIDS Res Hum Retroviruses 1997;13:63-69.
48. Biesinger B, Muller-Fleckenstein I, Simmer B, Lang G, Wittmann S, Platzer E, Desrosiers R, and Fleckenstein B: Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci USA 1992;89:3116-3119.
49. Broker BM, Tsyankov AY, Muller-Fleckenstein I, Guse AH, Chitaev NA, Biesinger B, Fleckenstein B, and Emmrich F: Immortalisation of human T cell clones by herpesvirus saimiri. J Immunol 1993;151:1184-1192.
50. Goff S, Traktman P, and Baltimore D: Isolation and properties of Moloney murine leukemia virus mutants: Use of a rapid assay for release of virion reverse transcriptase. J Virol 1981;38:239-248.
51. Willey RL, Smith DS, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, and Martin MA: In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 1988;62:139-147.
52. Biesinger B, Trimble JJ, Desrosiers RC, and Fleckenstein B: The divergence between two oncogenic herpesvirus saimiri strains in a genomic region related to the transforming phenotype. Virology 1990;176:505-514.
53. Toso JF, Chen C-H, Mohr JR, Piglia L, Oei C, Ferrari G Greenberg ML, and Weinhold KJ: Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication. J Infect Dis 1995;172: 964-973.
54. Jung JU, Trimble JJ, King NW, Biesinger B, Fleckenstein B, and Desrosiers RC: Identification of the transforming genes of subgroup A and C strains of herpesvirus saimiri. Proc Natl Acad Sci USA 1991;89:7051-7055.
55. Koot M, Vos AHV, Keet RPM, de Goede REY, Dercksen MW, Terpstra FG, Coutinho RA, Miedema F, and Tersmette M: HIV-1 biological phenotype in long-term infected individuals evaluated with an MT2 cocultivation assay. AIDS 1992;6:49-54.
56. Scala E, D'Offizi G, Rosso R, Turriziani O, Ferrara R, Mazzone AM, Antonelli G, Aiuti F, and Paganelli R: C-C chemokines, IL-16 and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J Immun 1997;158:4485-4492.
57. + T cell lines with noncytotoxic anti-HIV activity. Clin Immunol Immunopathol 1997;82:274-281.